Tg Therapeutics (TGTX) Assets Average: 2016-2025
Historic Assets Average for Tg Therapeutics (TGTX) over the last 10 years, with Sep 2025 value amounting to $863.8 million.
- Tg Therapeutics' Assets Average rose 75.00% to $863.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $863.8 million, marking a year-over-year increase of 75.00%. This contributed to the annual value of $453.6 million for FY2024, which is 73.42% up from last year.
- Tg Therapeutics' Assets Average amounted to $863.8 million in Q3 2025, which was up 27.10% from $679.7 million recorded in Q2 2025.
- In the past 5 years, Tg Therapeutics' Assets Average registered a high of $863.8 million during Q3 2025, and its lowest value of $195.5 million during Q1 2023.
- For the 3-year period, Tg Therapeutics' Assets Average averaged around $453.2 million, with its median value being $387.3 million (2024).
- In the last 5 years, Tg Therapeutics' Assets Average soared by 343.38% in 2021 and then crashed by 47.87% in 2022.
- Over the past 5 years, Tg Therapeutics' Assets Average (Quarterly) stood at $394.7 million in 2021, then slumped by 47.87% to $205.7 million in 2022, then surged by 60.56% to $330.3 million in 2023, then spiked by 76.14% to $581.9 million in 2024, then skyrocketed by 75.00% to $863.8 million in 2025.
- Its Assets Average stands at $863.8 million for Q3 2025, versus $679.7 million for Q2 2025 and $617.2 million for Q1 2025.